AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇬🇭
Lamivudine/Tenofovir Disoproxil Fumarate in Ghana
2 products registered with FDA Ghana — 2 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| LAMIVUDINE/TENOFOVIR DISOPROXIL FUMARATE 300MG/300MG TABLETS (Each film-coated tablet contains Lamivudine/Tenofovir Disoproxil Fumarate 300mg/300mg) | UNKNOWN-de293b6a | — | active | 1 Jul 2031 |
| LAMIVUDINE/TENOFOVIR DISOPROXIL FUMARATE 300MG/300MG TABLETS (Each film-coated tablet contains Lamivudine/Tenofovir Disoproxil Fumarate 300mg/300mg) | UNKNOWN-693675b6 | — | active | 1 Jul 2031 |
Lamivudine/Tenofovir Disoproxil Fumarate — FDA Ghana Registration Details
FDA Ghana (Ghana) has 2 registered products containing Lamivudine/Tenofovir Disoproxil Fumarate, of which 2 are currently active. Data is sourced directly from the official FDA Ghana drug register and refreshed daily.
Track Lamivudine/Tenofovir Disoproxil Fumarate registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.